首页> 外国专利> IDENTIFICATION OF CANCER PATIENTS SENSITIVE OR RESISTANT TO 5-FLUOROURACIL (5-FU)

IDENTIFICATION OF CANCER PATIENTS SENSITIVE OR RESISTANT TO 5-FLUOROURACIL (5-FU)

机译:对5-氟尿嘧啶(5-FU)敏感或耐药的癌症患者的鉴定

摘要

Methods are provided for quantifying the TYMS, TYMP, UCK1, UCK2, UPP1, OPRT, dCK, TK1, DPYD, CDA, RRM1, and/or RRM2 proteins directly in biological samples that have been fixed in formalin by the method of Selected Reaction Monitoring/Multiple Reaction Monitoring (SRM/MRM). The biological samples are chemically preserved with formaldehyde-containing agents/fixatives including formalin-fixed tissue/cells, formalin-fixed/paraffin embedded (FFPE) tissue/cells, FFPE tissue blocks and cells from those blocks, and tissue culture cells that have been formalin fixed and or paraffin embedded. A protein digest sample is prepared from the biological sample and the TYMS, TYMP, UCK1, UCK2, UPP1, OPRT, dCK, TK1, DPYD, CDA, RRM1, and/or RRM2 proteins are quantitated in the digest by SRM/MRM mass spectrometry.
机译:提供了直接通过选择反应监测方法固定在福尔马林中固定的生物样品中的TYMS,TYMP,UCK1,UCK2,UPP1,OPRT,dCK,TK1,TKY,DPYD,CDA,RRM1和/或RRM2蛋白的定量方法/多反应监测(SRM / MRM)。生物样品用含甲醛的试剂/固定剂化学保存,包括甲醛固定的组织/细胞,甲醛固定的/石蜡包埋的(FFPE)组织/细胞,FFPE组织块和来自那些块的细胞,以及已经被分离的组织培养细胞。福尔马林固定和/或石蜡包埋。从生物样品中制备蛋白质消化样品,然后通过SRM / MRM质谱对TYMS,TYMP,UCK1,UCK2,UPP1,OPRT,dCK,TK1,DPYD,CDA,RRM1和/或RRM2蛋白进行定量。 。

著录项

  • 公开/公告号US2019353660A1

    专利类型

  • 公开/公告日2019-11-21

    原文格式PDF

  • 申请/专利权人 NANTOMICS LLC;

    申请/专利号US201916412611

  • 申请日2019-05-15

  • 分类号G01N33/574;

  • 国家 US

  • 入库时间 2022-08-21 11:20:56

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号